Stay updated with breaking news from Brook Baker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.
The company behind a COVID-19 vaccine touted as a key tool for the developing world will miss a target for giving doses to the U.N.-backed effort to deliver shots to poorer countries.
NEW DELHI -- The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic.
Novavax will miss a target for giving COVID-19 vaccine doses to the U.N.-backed effort to deliver shots to poorer countries.
Quarter-million doses from vaccine company were supposed to be available to COVAX by March but first shipments now likely won't be made until April or May